Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209– 49.
DOI: 10.3322/caac.21660
Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021:71(1):7–33.
DOI: 10.3322/caac.21654
Simone G. The epidemiology of prostate cancer. In: Prostate Cancer. Ed. by S.R.J. Bott, K.L. Ng. Australia, Brisbane: Exon Publications, 2021. 158 p.
Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 252 с.
EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022.
Haahr M.K., Jensen C.H., Toyserkani N.M. et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine 2016;5:204–10.
DOI: 10.1016/j.ebiom.2016.01.024
Huri M., Akel B.S., Sahin S. Rehabilitation of patients with prostate cancer. In: Prostate cancer – leading-edge diagnostic procedures and treatments. Ed. by R. Mohan. London: IntechOpen, 2016. Pp. 227–248.
DOI: 10.5772/63989
Ladegaard P.B.J., Mortensen J., Skov-Jeppesen S.M., Lund L. Erectile dysfunction a prospective randomized placebo-controlled study evaluating the effect of low-intensity extracorporeal shockwave therapy (LI-ESWT) in men with erectile dysfunction following radical prostatectomy. Sex Med 2021;9(3):100338.
DOI: 10.1016/j.esxm.2021.100338
Avulova S., Zhao Z., Lee D. et al. The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR study. J Urol 2018;199(5):1202–9.
DOI: 10.1016/j.juro.2017.12.037
Ko Y.H., Coelho R.F., Sivaraman A. et al. Retrograde versus antegrade nerve sparing during robot-assisted radical prostatectomy: which is better for achieving early functional recovery? Eur Urol 2013;63(1):169–77.
DOI: 10.1016/j.eururo.2012.09.051
Alemozaffar M., Duclos A., Hevelone N.D. et al. Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol 2012;61(6):1222–8.
DOI: 10.1016/j.eururo.2012.02.053
Шпоть Е.В., Чиненов Д.В., Чернов Я.Н. и др. Сравнительные результаты нервосберегающей робот-ассистированной простатэктомии. Андрология и генитальная хирургия 2021;22(3):44–8.
DOI: 10.17650/1726-9784-2021-22-3-44-48.
Emanu J.C., Avildsen I.K., Nelson C.J. Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions. Curr Opin Support Palliat Care 2016;10(1):102–7.
DOI: 10.1097/SPC.0000000000000195
Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005;6(11):889–98.
DOI: 10.1038/nrn1788
Whalen M. Preventing erectile dysfunction after radical prostatectomy: nerve-sparing techniques, penile rehabilitation, and novel regenerative therapies. In: Prostatectomy. Ed. by T. Genadiev. London: IntechOpen, 2019. Pp. 129–174.
Bratu O., Oprea I., Marcu D. et al. Erectile dysfunction postradical prostatectomy – a challenge for both patient and physician. J Med Life 2017;10(1):13–18
Wang L., Sanford M.T., Xin Z. et al. Role of Schwann cells in the regeneration of penile and peripheral nerves. Asian J Androl 2015;17(5):776–82.
DOI: 10.4103/1008-682X.154306
Lagoda G., Sezen S.F., Burnett A.L. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury. J Sex Med 2009;6(7):1914–23.
DOI: 10.1111/j.1743-6109.2009.01293.x
Leungwattanakij S., Bivalacqua T.J., Usta M.F. et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24(2):239–45.
DOI: 10.1002/j.1939-4640.2003.tb02668.x
Cui Y., Liu X., Shi L., Gao Z. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Andrologia 2016;48(1):20–8.
DOI: 10.1111/and.12405
Hamilton Z., Mirza M. Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective. Res Rep Urol 2014;6:35–41.
DOI: 10.2147/RRU.S39560
Hebert K.J., Kohler T.S. Glans ischemia following inflatable penile prosthesis surgery. Transl Androl Urol 2020;9(2):824–7.
DOI: 10.21037/tau.2020.01.04
Lokeshwar S.D., Patel P., Shah S.M., Ramasamy R. A systematic review of human trials using stem cell therapy for erectile dysfunction. Sex Med Rev 2020;8(1):122–30.
DOI: 10.1016/j.sxmr.2019.08.003
Epifanova M.V., Gvasalia B.R., Durashov M.A., Artemenko S.A. Platelet-rich plasma therapy for male sexual dysfunction: myth or reality? Sex Med Rev 2020;8(1):106–13.
DOI: 10.1016/j.sxmr.2019.02.002
EAU Guidelines. Edn. presented at the EAU Annual Congress Milan, 2021.
Yao H., Wang X., Liu H. et al. Systematic review and meta-analysis of 16 randomized controlled trials of clinical outcomes of lowintensity extracorporeal shock wave therapy in treating erectile dysfunction. Am J Mens Health 2022;16(2):15579883221087532.
DOI: 10.1177/15579883221087532
Епифанова М.В. Применение аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Дис. … канд. мед. наук. М., 2016. 167 с.
Епифанова М.В. Применение технологий регенеративной медицины при сексуальной дисфункции и нарушении фертильности у мужчин. Дис. … д-ра. мед. наук. М., 2022. 400 с.
Lee J.W., Kwon O.H., Kim T.K. et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013;40(5):530–5.
DOI: 10.5999/aps.2013.40.5.530
Nishio H., Saita Y., Kobayashi Y. et al. Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing. Regen Ther 2020;14:262–70.
DOI: 10.1016/j.reth.2020.03.009
Wang Z., Mudalal M., Sun Y. et al. The effects of leukocyte-platelet rich fibrin (L-PRF) on suppression of the expressions of the proinflammatory cytokines, and proliferation of Schwann cell, and neurotrophic factors. Sci Rep 2020;10(1):2421.
DOI: 10.1038/s41598-020-59319-2
Pereira C.T., Paxton Z.J., Li A.I. Involvement of PDGF-BB and IGF-1 in activation of human Schwann cells by platelet-rich plasma. Plast Reconstr Surg 2020;146(6):825e–7e.
DOI: 10.1097/PRS.0000000000007406
Zheng C., Zhu Q., Liu X. et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 2016;10(5):428–36.
DOI: 10.1002/term.1756
Pelletier J., Roudier E., Abraham P. et al. VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats. Mol Neurobiol 2015;51(1):240–51.
DOI: 10.1007/s12035-014-8754-1
Hatanaka K., Ito K., Shindo T. et al. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol 2016;311(3):C378–85.
DOI: 10.1152/ajpcell.00152.2016
Pan M.M., Raees A., Kovac J.R. Low-intensity extracorporeal shock wave as a novel treatment for erectile dysfunction. Am J Mens Health 2016;10(2):146–8.
DOI: 10.1177/1557988315574511
Yahata K., Kanno H., Ozawa H. et al. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury. J Neurosurg Spine 2016;25(6):745–5.
DOI: 10.3171/2016.4.SPINE15923
Jeong H.C., Bae W.J., Zhu G.Q. et al. Synergistic effects of extracorporeal shockwave therapy and modified Ojayeonjonghwan on erectile dysfunction in an animal model of diabetes. Investig Clin Urol 2019;60(4):285–94.
DOI: 10.4111/icu.2019.60.4.285
Jeon S.H., Shrestha K.R., Kim R.Y. et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology 2016;88:226.e1–9.
DOI: 10.1016/j.urology.2015.10.021
Lin G., Reed-Maldonado A.B., Wang B. et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med 2017;14(4):493–501.
DOI: 10.1016/j.jsxm.2017.02.004
Patel A.N., Selzman C.H., Kumpati G.S. et al. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg 2016;11(1):62.
DOI: 10.1186/s13019-016-0452-9
Gentile P., Di Pasquali C., Bocchini I. et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg Innov 2013;20(4):370–6.
DOI: 10.1177/1553350612458544
Spartalis E.D., Tomos P., Dimitroulis D., Kouraklis G. Platelet-rich plasma in surgical oncology. Surg Innov 2014;21(4):441.
DOI: 10.1177/1553350613520516
Spartalis E.D., Tomos P., Konofaos P. et al. Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient’s survival? Int J Clin Exp Med 2014;7(1):329–30
Guo X., Wu Y., Hathaway H.J., Hartley R.S. Microenvironmental control of the breast cancer cell cycle. Anat Rec (Hoboken) 2012;295(4):553–62.
DOI: 10.1002/ar.22417
Levva S., Kotoula V., Kostopoulos I. et al. Prognostic evaluation of epidermal growth factor receptor (EGFR) genotype and phenotype parameters in triple-negative breast cancers. Cancer Genomics Proteomics 2017;14(3):181–95.
DOI: 10.21873/cgp.20030
Spartalis E., Tsilimigras D.I., Charalampoudis P. et al. The “Yin and Yang” of platelet-rich plasma in breast reconstruction after mastectomy or lumpectomy for breast cancer. Anticancer Res 2017;37(12):6557–62.
DOI: 10.1016/j.gene.2019.04.025
Luzo A.C.M., Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon 2020;6(3):e03660.
DOI: 10.1016/j.heliyon.2020.e03660
Eichler C., Baucks C., Üner J. et al. Platelet-rich plasma (PRP) in breast cancer patients: an application analysis of 163 sentinel lymph node biopsies. Biomed Res Int 2020;2020:3432987.
DOI: 10.1155/2020/3432987
Haahr M.K., Harken C., Toyserkani N.M. et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology 2018;121:203.e6–203.e13.
DOI: 10.1016/j.urology.2018.06.018
Ding X.G., Li S.W., Zheng X.M. et al. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl 2009;11(2):215–21.
DOI: 10.1038/aja.2008.37
Wu C.C., Wu Y.N., Ho H.O. et al. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med 2012;9(11):2838–48.
DOI: 10.1111/j.1743-6109.2012.02881.x
Wu Y.N., Wu C.C., Sheu M.T. et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med 2016;10(10):E294–E304.
DOI: 10.1002/term.1806
Wu Y.N., Liao C.H., Chen K.C., Chiang H.S. Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injury. J Formos Med Assoc 2022;121(1 Pt 1):14–24.
DOI: 10.1016/j.jfma.2021.01.019
Gettman M. A Study evaluating intraoperative application of platelet-rich plasma to the neurovascular bundles during nervesparing radical prostatectomy: initial technical description and prospective early postoperative outcomes analysis. Available at:https://clinicaltrials.gov/ct2/show/NCT02957149
Porst H. Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), Peyronie’s disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 2021;9(1):93–122.
DOI: 10.1016/j.sxmr.2020.01.006
Frey A., Sønksen J., Fode M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol 2016;50(2):123–7.
DOI: 10.3109/21681805.2015.1100675
Zewin T.S., El-Assmy A., Harraz A.M. et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol 2018;50(11):2007–14.
DOI: 10.1007/s11255-018-1987-6
Baccaglini W., Pazeto C.L., Corrêa Barros E.A. et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med 2020;17(4):688–94.
DOI: 10.1016/j.jsxm.2019.12.024
Епифанова М.В., Каприн А.Д., Костин А.А. и др. Способ лечения эректильной дисфункции у пациентов, перенесших радикальную простатэктомию или брахитерапию. Патент на изобретение RU 2 741 204 C2, 22.01.2021. Бюлл. № 16 от 04.06.2020.